查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1794771

全球整形外科植入金黄色葡萄球菌感染疾病诊断与治疗市场

Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 278 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球整形外科植入金黄色葡萄球菌感染疾病诊断和治疗市场规模将达到 30 亿美元

全球整形外科植入金黄色葡萄球菌感染疾病诊断和治疗市场规模预计在2024年达到24亿美元，预计2024年至2030年期间的复合年增长率为3.2%，到2030年将达到30亿美元。诊断是本报告分析的细分市场之一，预计其复合年增长率为2.4%，到分析期结束时将达到17亿美元。治疗细分市场在分析期间内的复合年增长率预计为4.5%。

美国市场规模估计为 6.661 亿美元，中国市场预计复合年增长率为 5.9%

预计到2024年，美国整形外科植入金黄色葡萄球菌感染疾病诊断和治疗市场规模将达到6.661亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到5.795亿美元，在2024-2030年的分析期间内，复合年增长率为5.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为1.3%和2.4%。在欧洲，预计德国市场的复合年增长率为1.8%。

全球整形外科植入诊断和治疗市场中的金黄色葡萄球菌感染疾病—主要趋势和驱动因素摘要

是什么推动了整形外科植入中金黄色葡萄球菌检测的进步？

金黄色葡萄球菌（S. aureus），尤其是其抗甲氧西林菌株（MRSA），是整形外科植入中假体周围关节感染（PJIs）的主要原因。这些感染疾病可导致严重的併发症，包括植入断裂、骨髓炎和败血症。快速准确的检测和有针对性的治疗对于临床结果至关重要。传统的诊断依赖微生物培养，这既耗时又经常产生假阴性结果。如今，PCR、次世代定序（NGS）和免疫测量等分子诊断方法能够早期可靠地检测金黄色葡萄球菌和相关的生物膜形成病原体。

FDG-PET 和 WBC 标记 SPECT/CT 等先进影像技术也被用于感染定位。能够检测抗药性基因（例如 mecA）的即时生物感测器和多重检测板也正在进入临床应用。这些工具正在帮助骨科医生和感染疾病专家更快地做出更明智的清创手术和抗生素选择。

新的治疗方法和涂层会改变植入植入的照护吗？

抗菌涂层的创新，例如银奈米颗粒、抗生素水门汀和碘活化表面，正被应用于诊断以外的领域，以防止植入上形成生物膜。基于病原体基因图谱的个人化抗生素治疗方案正在提高根除率。长效抗生素载体（微珠、间隔物）可实现局部药物输送，且不产生全身毒性。

人们正在探索将诊断和治疗结合到单一植入或涂层中用于术中应用，而免疫疗法和基于噬菌体的抗菌疗法正在临床开发中，以更特异性针对抗生素抗药性菌株。

为什么整形外科专家强调早期治疗？

随着全球膝关节、髋关节和脊椎移植使用量的不断增加，感染预防和控制已成为重中之重。金黄色葡萄球菌感染疾病显着增加再次手术率、住院时间和医疗费用。外科医生正在寻求能够在手术过程中即时识别病原体的工具，以避免不必要的拔牙。医院正在采用全面的感染控制通讯协定，包括术前筛检、术中诊断和术后监测。

是什么推动了整形外科黄色葡萄球菌感染疾病市场的成长？

这一市场成长受到多种因素的推动，这些因素与整形外科手术量、诊断技术的创新以及抗药性趋势有关。全球全关节重建的兴起，增加了植入相关感染的风险和发生率。快速分子诊断和生物膜成像工具的技术进步正在提高临床检出率。新型抗菌材料和局部给药系统正在拓展治疗方案。最后，抗生素抗药性的上升刺激了对新型疗法的投资，从而催生了对整形外科领域精准、主动的感染控制解决方案的需求。

部分

组件（诊断、治疗）；最终用途（医院最终用途、门诊手术中心最终用途、其他最终用途）

受访公司范例

  • Abbott Laboratories
  • Beckman Coulter Inc.
  • Becton Dickinson（BD）
  • BioMerieux SA
  • C2Dx, Inc.
  • Cepheid
  • Hologic（Molecular Diagnostics）
  • Johnson & Johnson MedTech
  • MediWound
  • Merck KGaA
  • Micreos（Staphefekt）
  • Ortho Clinical Diagnostics
  • Pfizer Inc.
  • Roche（Roche Diagnostics）
  • Sabiad
  • Schwitz Biotech
  • Siemens Healthineers
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • Wellona Pharma

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP38106

Global Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market to Reach US$3.0 Billion by 2030

The global market for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants estimated at US$2.4 Billion in the year 2024, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 3.2% over the analysis period 2024-2030. Diagnosis, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Treatment segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$666.1 Million While China is Forecast to Grow at 5.9% CAGR

The Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants market in the U.S. is estimated at US$666.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$579.5 Million by the year 2030 trailing a CAGR of 5.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market - Key Trends & Drivers Summarized

What’s Driving Advances in Staphylococcus Aureus Detection in Orthopedic Implants?

Staphylococcus aureus (S. aureus), particularly its methicillin-resistant strain (MRSA), is a major cause of periprosthetic joint infections (PJI) in orthopedic implants. These infections can lead to severe complications, including implant failure, osteomyelitis, and sepsis. Rapid, accurate detection and targeted treatment are critical for clinical outcomes. Conventional diagnosis relied on microbial culture, which is slow and often yields false negatives. Today, molecular diagnostics-like PCR, next-generation sequencing (NGS), and immunoassays-are enabling earlier and more reliable detection of S. aureus and associated biofilm-forming pathogens.

Advanced imaging modalities, such as FDG-PET and WBC-labeled SPECT/CT, are also being used to localize infections. Point-of-care biosensors and multiplexed panels capable of detecting resistance genes (e.g., mecA) are entering clinical use. These tools help orthopedic surgeons and infectious disease specialists make informed debridement and antibiotic choices more quickly.

Are Novel Therapies and Coatings Transforming Post-Implant Management?

Beyond diagnostics, innovations in antimicrobial coatings-silver nanoparticles, antibiotic-loaded cements, and iodine-activated surfaces-are being employed to prevent biofilm formation on implants. Personalized antibiotic regimens based on genetic profiling of pathogens are improving eradication rates. Long-acting antibiotic carriers (beads, spacers) provide localized drug delivery without systemic toxicity.

Theranostic approaches-where diagnosis and therapy are combined in a single implant or coating-are being explored for intraoperative applications. Immunotherapies and phage-based antibacterial therapies are under clinical development, targeting antibiotic-resistant strains with greater specificity.

Why Are Orthopedic Specialists Focusing on Early Intervention?

As the global volume of knee, hip, and spinal implants rises, infection prevention and control have become top priorities. S. aureus infections significantly increase revision rates, hospitalization duration, and costs. Surgeons are demanding tools that enable real-time pathogen identification during surgery to avoid unnecessary explantation. Hospitals are adopting comprehensive infection management protocols-including preoperative screening, intraoperative diagnostics, and post-op surveillance.

What’s Powering the Growth in the Orthopedic S. Aureus Infection Market?

The growth in this market is driven by several factors related to orthopedic surgery volumes, diagnostic innovation, and resistance trends. The rise in joint replacement procedures globally is increasing risk and incidence of implant-related infections. Technological advancements in rapid molecular diagnostics and biofilm imaging tools are improving clinical detection rates. New antimicrobial materials and localized drug-delivery systems are expanding treatment options. Finally, the spread of antibiotic resistance is fueling investment in novel therapies, creating demand for precise and aggressive infection control solutions in orthopedic settings.

SCOPE OF STUDY:

The report analyzes the Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Diagnosis, Treatment); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Beckman Coulter Inc.
  • Becton Dickinson (BD)
  • BioMerieux SA
  • C2Dx, Inc.
  • Cepheid
  • Hologic (Molecular Diagnostics)
  • Johnson & Johnson MedTech
  • MediWound
  • Merck KGaA
  • Micreos (Staphefekt)
  • Ortho Clinical Diagnostics
  • Pfizer Inc.
  • Roche (Roche Diagnostics)
  • Sabiad
  • Schwitz Biotech
  • Siemens Healthineers
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • Wellona Pharma

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Post-Operative Infections Drives Demand for Advanced Diagnostic Solutions
    • Increase in Joint Replacement and Trauma Surgeries Spurs Need for S. aureus Monitoring
    • Growing Focus on Implant-Associated Infections Throws Spotlight on Early Detection Technologies
    • Development of Rapid Molecular Diagnostics Enhances Clinical Decision-Making
    • Antimicrobial Coating Innovations Strengthen Business Case for Preventative Orthopedic Implants
    • Regulatory Guidelines for Surgical Site Infections Drive Compliance-Based Adoption
    • AI and Machine Learning in Diagnostic Algorithms Accelerate Infection Identification Accuracy
    • Expansion of Outpatient Orthopedic Care Creates Demand for Point-of-Care Testing Kits
    • Rise in Antibiotic Resistance Fuels R&D in Novel Therapeutics and Diagnostic Pathways
    • Healthcare Cost Containment Strategies Encourage Early Diagnosis and Treatment
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Diagnosis and Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Component - Percentage Breakdown of Value Sales for Diagnosis and Treatment for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION